Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001588428 | SCV001822806 | likely benign | not provided | 2019-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039524 | SCV004927224 | uncertain significance | Inborn genetic diseases | 2023-12-28 | criteria provided, single submitter | clinical testing | The c.504T>A (p.N168K) alteration is located in exon 5 (coding exon 4) of the CIT gene. This alteration results from a T to A substitution at nucleotide position 504, causing the asparagine (N) at amino acid position 168 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |